Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Diphenidol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 known ✓ | P11229 | 11/20 | 1.00 |
| ▸ | CHRM3 | P20309 | 12/20 | 1.00 |
| ▸ | CHRM4 | P08173 | 11/20 | 1.00 |
| ▸ | CHRM2 | P08172 | 11/20 | 1.00 |
| ▸ | CHRM5 | P08912 | 10/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 6/20 | 1.00 |
| ▸ | KCNH2 | Q12809 | 4/20 | 1.00 |
| ▸ | HTR1A | P08908 | 3/20 | 1.00 |
| ▸ | OPRM1 | P35372 | 3/20 | 1.00 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 1.00 |
| ▸ | DRD2 | P14416 | 1/20 | 1.00 |
| ▸ | DRD1 | P21728 | 1/20 | 1.00 |
| ▸ | HTR2A | P28223 | 1/20 | 1.00 |
| ▸ | DRD3 | P35462 | 1/20 | 1.00 |
| ▸ | SCN1A | P35498 | 1/20 | 1.00 |
| ▸ | SCN2A | Q99250 | 1/20 | 1.00 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 0.97 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.97 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Diphenidol SCHEMBL195192 | 0.98 | CHRM3 (1.00) | CHRM3CHRM4CHRM2CHRM1CHRM5 | |
| SCHEMBL10307554 | 0.98 | CHRM3 (0.97) | CHRM3CHRM4CHRM2CHRM1CHRM5 | |
| Diphenidol SCHEMBL15531902 | 0.97 | CHRM3 (0.94) | CHRM3CHRM4CHRM2CHRM1CHRM5 | |
| Pridinol SCHEMBL143298 | 0.90 | CHRM2 (1.00) | CHRM3CHRM4CHRM2CHRM1CHRM5 | |
| SCHEMBL7436541 | 0.88 | CHRM3 (0.78) | CHRM3CHRM4CHRM2CHRM1CHRM5 | |
| Pridinol SCHEMBL363996 | 0.88 | CHRM2 (0.97) | CHRM3CHRM4CHRM2CHRM1CHRM5 | |
| Pridinol SCHEMBL29250415 | 0.88 | CHRM2 (0.97) | CHRM3CHRM4CHRM2CHRM1CHRM5 | |
| Pridinol SCHEMBL27496509 | 0.88 | CHRM2 (0.97) | CHRM3CHRM4CHRM2CHRM1CHRM5 | |
| SCHEMBL8967625 | 0.84 | CHRM2 (0.72) | CHRM3CHRM4CHRM2CHRM1CHRM5 | |
| SCHEMBL10307563 | 0.83 | CHRM4 (0.70) | CHRM3CHRM4CHRM2CHRM1CHRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5955 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122072257-A | Method for rapidly detecting poison in blood | 中国科学院大连化学物理研究所 | 2026-05-22 | — | — | CN | claimed |
| WO-2026100654-A1 | NUCLEIC ACID INTRODUCTION AID, NUCLEIC ACID INTRODUCTION AGENT, AND NUCLEIC ACID INTRODUCTION METHOD | 株式会社インファーマシア | 2026-05-15 | — | — | WO | claimed |
| US-20250302814-A1 | METHODS AND COMPOSITIONS FOR TREATING SLEEP APNEA | APNIMED, INC. (DELAWARE) | 2025-10-02 | — | — | US | claimed |
| US-20250271426-A1 | REDUCTION OF BITTER TASTE OF ACTIVE PHARMACEUTICAL INGREDIENTS AND RELATED ASSAYS AND SCREENING METHODS | FIRMENICH INCORPORATED (US) | 2025-08-28 | — | — | US | claimed |
| US-20250241933-A1 | METHODS OF TREATING SLEEP APNEA WITH A COMBINATION OF A CANNABINOID AND A CARBONIC ANHYDRASE INHIBITOR | APNIMED, INC. (DELAWARE) | 2025-07-31 | — | — | US | claimed |
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| EP-4543431-A1 | METHODS OF TREATING SLEEP APNEA WITH A COMBINATION OF A CANNABINOID AND A CARBONIC ANHYDRASE INHIBITOR | APNIMED, INC. (DELAWARE) (US) | 2025-04-30 | — | — | EP | claimed |
| WO-2025073376-A1 | MASKING PREPARATIONS AND COMPOUNDS FROM DAEMONOROPS DRACO (DRAGON BLOOD) | SYMRISE AG (DE) | 2025-04-10 | — | — | WO | claimed |
| CN-119789855-A | Methods and compositions for treating sleep apnea | 爱普宁公司(特拉华) | 2025-04-08 | — | — | CN | claimed |
| WO-2025058054-A1 | METHOD FOR PROMOTING DIFFERENTIATION OF ANIMAL CELL | 味の素株式会社 | 2025-03-20 | — | — | WO | claimed |
| EP-0819001-A1 | USE OF SUBSTITUTED PIPERIDINE OR PYRROLIDINE COMPOUNDS FOR TREATING SIGMA-RECEPTOR MODULATED DISORDERS | Byk Gulden Lomberg Chemische Fabrik GmbH (DE) | 1998-01-21 | — | — | EP | claimed |
| US-5700410-A | Method of manufacturing wax matrices | NIPPON SHINYAKU CO., LTD. (JP) | 1997-12-23 | — | — | US | claimed |
| EP-0580860-B1 | METHOD OF MANUFACTURING SOLID DISPERSION | NIPPON SHINYAKU CO LTD (JP) | 1997-10-22 | — | — | EP | claimed |
| WO-1996031208-A2 | USE OF SUBSTITUTED PIPERIDINE OR PYRROLIDINE COMPOUNDS FOR TREATING SIGMA-RECEPTOR MODULATED DISORDERS | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1996-10-10 | — | — | WO | claimed |
| EP-0651993-A1 | PERCUTANEOUSLY ADMINISTRABLE BASE COMPOSITION AND DRUG COMPOSITION PREPARED THEREFROM | Hisamitsu Pharmaceutical Co., Inc. (JP) | 1995-05-10 | — | — | EP | claimed |
| EP-0559151-A1 | Traction controlling apparatus for a multi-axle vehicle | AKEBONO BRAKE INDUSTRY CO., LTD. (JP) | 1993-09-08 | — | — | EP | claimed |
| US-5023088-A | Drug delivery dispenser | ALZA CORPORATION (US) | 1991-06-11 | — | — | US | claimed |
| US-4557934-A | ALONG WITH A DIOL PYRROLIDONE OR AN AZACYCLOPENTAN-2-ONE | THE PROCTER & GAMBLE COMPANY (US) | 1985-12-10 | — | — | US | claimed |
| US-4111203-A | OSMOTIC SYSTEM WITH MEANS FOR IMPROVING DELIVERY KINETICS OF SYSTEM | ALZA CORPORATION (US) | 1978-09-05 | — | — | US | claimed |
| US-4007273-A | Treatment and pre-treatment of dysmetric dyslexia by improving sequential scanning and ocular fixation abilities and therapeutic compounds | LEVINSON HAROLD N | 1977-02-08 | — | — | US | claimed |